Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Guangzhou Manjing Biomedicine Technology Co., Ltd

Clinical trials sponsored by Guangzhou Manjing Biomedicine Technology Co., Ltd, explained in plain language.

Not yet recruiting 1

New drug NT-88 aims to improve heart function in early trial

Disease control Not yet recruiting

This study tests a new drug called NT-88 (Zuozhu Daxi) in 60 adults with heart failure where the heart's pumping ability is mildly reduced. Participants will receive either standard heart failure drugs or standard drugs plus NT-88. The goal is to check safety and see if NT-88 can…

Phase: NA • Sponsor: Guangzhou Manjing biomedicine technology co., ltd • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC